Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.
Clinical trial NCT03144843 · UNKNOWN
Trial details
- NCT number
- NCT03144843
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-13
- Primary completion
- 2020-01-31
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.